nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CES1—Capecitabine—kidney cancer	0.358	0.5	CbGbCtD
Ciclesonide—CYP2D6—Temsirolimus—kidney cancer	0.0606	0.0847	CbGbCtD
Ciclesonide—CYP3A4—Everolimus—kidney cancer	0.0571	0.0797	CbGbCtD
Ciclesonide—CYP3A4—Temsirolimus—kidney cancer	0.0385	0.0538	CbGbCtD
Ciclesonide—CYP2D6—Pazopanib—kidney cancer	0.0318	0.0445	CbGbCtD
Ciclesonide—CYP2D6—Erlotinib—kidney cancer	0.0227	0.0317	CbGbCtD
Ciclesonide—CYP3A4—Pazopanib—kidney cancer	0.0202	0.0283	CbGbCtD
Ciclesonide—CYP2D6—Sorafenib—kidney cancer	0.0185	0.0258	CbGbCtD
Ciclesonide—CYP2D6—Vinblastine—kidney cancer	0.0182	0.0255	CbGbCtD
Ciclesonide—CYP3A4—Erlotinib—kidney cancer	0.0144	0.0202	CbGbCtD
Ciclesonide—CYP3A4—Paclitaxel—kidney cancer	0.0132	0.0185	CbGbCtD
Ciclesonide—CYP3A4—Sorafenib—kidney cancer	0.0117	0.0164	CbGbCtD
Ciclesonide—CYP3A4—Vinblastine—kidney cancer	0.0116	0.0162	CbGbCtD
Ciclesonide—CYP3A4—Vincristine—kidney cancer	0.0114	0.0159	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—kidney cancer	0.0112	0.0157	CbGbCtD
Ciclesonide—CYP3A4—Sunitinib—kidney cancer	0.00952	0.0133	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—kidney cancer	0.00713	0.00996	CbGbCtD
Ciclesonide—NR3C1—urine—kidney cancer	0.00319	0.145	CbGeAlD
Ciclesonide—CYP3A4—urine—kidney cancer	0.00241	0.11	CbGeAlD
Ciclesonide—CYP2D6—urine—kidney cancer	0.00237	0.108	CbGeAlD
Ciclesonide—Amcinonide—ANXA1—kidney cancer	0.00236	0.535	CrCbGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00216	0.0811	CbGpPWpGaD
Ciclesonide—SERPINA6—nephron tubule—kidney cancer	0.00196	0.0893	CbGeAlD
Ciclesonide—SERPINA6—renal system—kidney cancer	0.00178	0.0812	CbGeAlD
Ciclesonide—CES1—Irinotecan Pathway—BCHE—kidney cancer	0.00174	0.0651	CbGpPWpGaD
Ciclesonide—SERPINA6—kidney—kidney cancer	0.00172	0.0785	CbGeAlD
Ciclesonide—SERPINA6—cortex of kidney—kidney cancer	0.00168	0.0765	CbGeAlD
Ciclesonide—CES1—E2F transcription factor network—TFE3—kidney cancer	0.0012	0.0448	CbGpPWpGaD
Ciclesonide—Hydrocortisone—ANXA1—kidney cancer	0.000995	0.225	CrCbGaD
Ciclesonide—CES1—Irinotecan Pathway—APC—kidney cancer	0.000943	0.0354	CbGpPWpGaD
Ciclesonide—NR3C1—nephron tubule—kidney cancer	0.000858	0.0391	CbGeAlD
Ciclesonide—NR3C1—renal system—kidney cancer	0.00078	0.0356	CbGeAlD
Ciclesonide—NR3C1—kidney—kidney cancer	0.000754	0.0344	CbGeAlD
Ciclesonide—NR3C1—cortex of kidney—kidney cancer	0.000735	0.0335	CbGeAlD
Ciclesonide—NR3C1—gonad—kidney cancer	0.0007	0.0319	CbGeAlD
Ciclesonide—NR3C1—cardiac atrium—kidney cancer	0.000699	0.0319	CbGeAlD
Ciclesonide—CES1—E2F transcription factor network—APAF1—kidney cancer	0.000645	0.0242	CbGpPWpGaD
Ciclesonide—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.00064	0.024	CbGpPWpGaD
Ciclesonide—CYP2D6—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000615	0.0231	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.000606	0.0227	CbGpPWpGaD
Ciclesonide—CYP3A4—renal system—kidney cancer	0.00059	0.0269	CbGeAlD
Ciclesonide—CYP2D6—renal system—kidney cancer	0.000581	0.0265	CbGeAlD
Ciclesonide—CYP3A4—kidney—kidney cancer	0.000571	0.026	CbGeAlD
Ciclesonide—CYP2D6—kidney—kidney cancer	0.000561	0.0256	CbGeAlD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.000541	0.0203	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.000516	0.0194	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—SLC5A3—kidney cancer	0.000499	0.0187	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.00048	0.018	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.000438	0.0164	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—KEAP1—kidney cancer	0.000436	0.0163	CbGpPWpGaD
Ciclesonide—Clobetasol propionate—CYP1A1—kidney cancer	0.000426	0.0964	CrCbGaD
Ciclesonide—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.000422	0.0158	CbGpPWpGaD
Ciclesonide—CYP2D6—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000413	0.0155	CbGpPWpGaD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000402	0.0151	CbGpPWpGaD
Ciclesonide—Nasopharyngitis—Paclitaxel—kidney cancer	0.000388	0.00168	CcSEcCtD
Ciclesonide—Dry mouth—Everolimus—kidney cancer	0.000388	0.00168	CcSEcCtD
Ciclesonide—Dysphonia—Doxorubicin—kidney cancer	0.000384	0.00166	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Paclitaxel—kidney cancer	0.000383	0.00166	CcSEcCtD
Ciclesonide—Chest pain—Erlotinib—kidney cancer	0.000383	0.00166	CcSEcCtD
Ciclesonide—Arthralgia—Erlotinib—kidney cancer	0.000383	0.00166	CcSEcCtD
Ciclesonide—Dysgeusia—Sunitinib—kidney cancer	0.000381	0.00165	CcSEcCtD
Ciclesonide—Infection—Everolimus—kidney cancer	0.000378	0.00164	CcSEcCtD
Ciclesonide—Back pain—Sunitinib—kidney cancer	0.000376	0.00163	CcSEcCtD
Ciclesonide—Influenza—Paclitaxel—kidney cancer	0.000375	0.00162	CcSEcCtD
Ciclesonide—Angioedema—Sorafenib—kidney cancer	0.000369	0.0016	CcSEcCtD
Ciclesonide—Asthenia—Temsirolimus—kidney cancer	0.000367	0.00159	CcSEcCtD
Ciclesonide—Infection—Erlotinib—kidney cancer	0.000364	0.00158	CcSEcCtD
Ciclesonide—Bronchitis—Paclitaxel—kidney cancer	0.000361	0.00156	CcSEcCtD
Ciclesonide—Haemoglobin—Gemcitabine—kidney cancer	0.00036	0.00156	CcSEcCtD
Ciclesonide—Rhinitis—Gemcitabine—kidney cancer	0.00036	0.00156	CcSEcCtD
Ciclesonide—Haemorrhage—Gemcitabine—kidney cancer	0.000359	0.00155	CcSEcCtD
Ciclesonide—Pain in extremity—Capecitabine—kidney cancer	0.000356	0.00154	CcSEcCtD
Ciclesonide—Pharyngitis—Gemcitabine—kidney cancer	0.000356	0.00154	CcSEcCtD
Ciclesonide—Angioedema—Sunitinib—kidney cancer	0.000356	0.00154	CcSEcCtD
Ciclesonide—Cough—Sorafenib—kidney cancer	0.000353	0.00153	CcSEcCtD
Ciclesonide—Hypertension—Sorafenib—kidney cancer	0.000349	0.00151	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000349	0.00151	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000346	0.0015	CcSEcCtD
Ciclesonide—Asthenia—Pazopanib—kidney cancer	0.000345	0.0015	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.000344	0.0129	CbGpPWpGaD
Ciclesonide—Arthralgia—Sorafenib—kidney cancer	0.000344	0.00149	CcSEcCtD
Ciclesonide—Face oedema—Capecitabine—kidney cancer	0.000344	0.00149	CcSEcCtD
Ciclesonide—Weight increased—Paclitaxel—kidney cancer	0.000341	0.00148	CcSEcCtD
Ciclesonide—Mediastinal disorder—Vincristine—kidney cancer	0.000341	0.00148	CcSEcCtD
Ciclesonide—Cough—Sunitinib—kidney cancer	0.00034	0.00147	CcSEcCtD
Ciclesonide—Dyspnoea—Everolimus—kidney cancer	0.000339	0.00147	CcSEcCtD
Ciclesonide—Dizziness—Temsirolimus—kidney cancer	0.000338	0.00146	CcSEcCtD
Ciclesonide—Dry mouth—Sorafenib—kidney cancer	0.000337	0.00146	CcSEcCtD
Ciclesonide—Pneumonia—Paclitaxel—kidney cancer	0.000336	0.00146	CcSEcCtD
Ciclesonide—Hypertension—Sunitinib—kidney cancer	0.000336	0.00145	CcSEcCtD
Ciclesonide—Dyspepsia—Everolimus—kidney cancer	0.000335	0.00145	CcSEcCtD
Ciclesonide—Infestation—Paclitaxel—kidney cancer	0.000334	0.00145	CcSEcCtD
Ciclesonide—Infestation NOS—Paclitaxel—kidney cancer	0.000334	0.00145	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—kidney cancer	0.000334	0.00145	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000334	0.00145	CcSEcCtD
Ciclesonide—Arthralgia—Sunitinib—kidney cancer	0.000331	0.00143	CcSEcCtD
Ciclesonide—Chest pain—Sunitinib—kidney cancer	0.000331	0.00143	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Everolimus—kidney cancer	0.000328	0.00142	CcSEcCtD
Ciclesonide—Infection—Sorafenib—kidney cancer	0.000328	0.00142	CcSEcCtD
Ciclesonide—Fatigue—Everolimus—kidney cancer	0.000328	0.00142	CcSEcCtD
Ciclesonide—Dyspnoea—Erlotinib—kidney cancer	0.000327	0.00142	CcSEcCtD
Ciclesonide—Urinary tract infection—Paclitaxel—kidney cancer	0.000325	0.00141	CcSEcCtD
Ciclesonide—Conjunctivitis—Paclitaxel—kidney cancer	0.000325	0.00141	CcSEcCtD
Ciclesonide—Dry mouth—Sunitinib—kidney cancer	0.000324	0.0014	CcSEcCtD
Ciclesonide—Immune system disorder—Gemcitabine—kidney cancer	0.000324	0.0014	CcSEcCtD
Ciclesonide—Mediastinal disorder—Gemcitabine—kidney cancer	0.000323	0.0014	CcSEcCtD
Ciclesonide—Dyspepsia—Erlotinib—kidney cancer	0.000323	0.0014	CcSEcCtD
Ciclesonide—Rash—Temsirolimus—kidney cancer	0.000322	0.0014	CcSEcCtD
Ciclesonide—Dermatitis—Temsirolimus—kidney cancer	0.000322	0.00139	CcSEcCtD
Ciclesonide—Headache—Temsirolimus—kidney cancer	0.00032	0.00139	CcSEcCtD
Ciclesonide—Nasopharyngitis—Capecitabine—kidney cancer	0.000319	0.00138	CcSEcCtD
Ciclesonide—Dizziness—Pazopanib—kidney cancer	0.000318	0.00138	CcSEcCtD
Ciclesonide—Back pain—Vincristine—kidney cancer	0.000318	0.00138	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000317	0.00137	CcSEcCtD
Ciclesonide—Fatigue—Erlotinib—kidney cancer	0.000316	0.00137	CcSEcCtD
Ciclesonide—Epistaxis—Paclitaxel—kidney cancer	0.000315	0.00137	CcSEcCtD
Ciclesonide—Infection—Sunitinib—kidney cancer	0.000315	0.00137	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000314	0.00136	CcSEcCtD
Ciclesonide—Sinusitis—Paclitaxel—kidney cancer	0.000314	0.00136	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.000311	0.0117	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.000311	0.0117	CbGpPWpGaD
Ciclesonide—Influenza—Capecitabine—kidney cancer	0.000308	0.00133	CcSEcCtD
Ciclesonide—Rash—Pazopanib—kidney cancer	0.000304	0.00131	CcSEcCtD
Ciclesonide—Nausea—Temsirolimus—kidney cancer	0.000304	0.00131	CcSEcCtD
Ciclesonide—Dermatitis—Pazopanib—kidney cancer	0.000303	0.00131	CcSEcCtD
Ciclesonide—Bronchospasm—Capecitabine—kidney cancer	0.000303	0.00131	CcSEcCtD
Ciclesonide—Back pain—Gemcitabine—kidney cancer	0.000302	0.00131	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—kidney cancer	0.000302	0.00131	CcSEcCtD
Ciclesonide—Haemoglobin—Paclitaxel—kidney cancer	0.000302	0.00131	CcSEcCtD
Ciclesonide—Headache—Pazopanib—kidney cancer	0.000302	0.00131	CcSEcCtD
Ciclesonide—Rhinitis—Paclitaxel—kidney cancer	0.000301	0.0013	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000301	0.0013	CcSEcCtD
Ciclesonide—Haemorrhage—Paclitaxel—kidney cancer	0.0003	0.0013	CcSEcCtD
Ciclesonide—Infection—Dactinomycin—kidney cancer	0.000299	0.00129	CcSEcCtD
Ciclesonide—Pharyngitis—Paclitaxel—kidney cancer	0.000298	0.00129	CcSEcCtD
Ciclesonide—Bronchitis—Capecitabine—kidney cancer	0.000296	0.00128	CcSEcCtD
Ciclesonide—Dyspnoea—Sorafenib—kidney cancer	0.000294	0.00127	CcSEcCtD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000292	0.0109	CbGpPWpGaD
Ciclesonide—Dyspepsia—Sorafenib—kidney cancer	0.00029	0.00126	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000289	0.00125	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000286	0.00124	CcSEcCtD
Ciclesonide—Nausea—Pazopanib—kidney cancer	0.000286	0.00124	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000285	0.00123	CcSEcCtD
Ciclesonide—Fatigue—Sorafenib—kidney cancer	0.000285	0.00123	CcSEcCtD
Ciclesonide—Hypertension—Vincristine—kidney cancer	0.000284	0.00123	CcSEcCtD
Ciclesonide—Dyspnoea—Sunitinib—kidney cancer	0.000283	0.00123	CcSEcCtD
Ciclesonide—Weight increased—Capecitabine—kidney cancer	0.00028	0.00121	CcSEcCtD
Ciclesonide—Dyspepsia—Sunitinib—kidney cancer	0.00028	0.00121	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.000277	0.0104	CbGpPWpGaD
Ciclesonide—Pneumonia—Capecitabine—kidney cancer	0.000276	0.0012	CcSEcCtD
Ciclesonide—Infestation—Capecitabine—kidney cancer	0.000274	0.00119	CcSEcCtD
Ciclesonide—Infestation NOS—Capecitabine—kidney cancer	0.000274	0.00119	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000274	0.00119	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000274	0.00119	CcSEcCtD
Ciclesonide—Asthenia—Vinblastine—kidney cancer	0.000274	0.00119	CcSEcCtD
Ciclesonide—Fatigue—Sunitinib—kidney cancer	0.000274	0.00119	CcSEcCtD
Ciclesonide—Asthenia—Everolimus—kidney cancer	0.000273	0.00118	CcSEcCtD
Ciclesonide—Cough—Gemcitabine—kidney cancer	0.000272	0.00118	CcSEcCtD
Ciclesonide—Immune system disorder—Paclitaxel—kidney cancer	0.000271	0.00117	CcSEcCtD
Ciclesonide—Mediastinal disorder—Paclitaxel—kidney cancer	0.000271	0.00117	CcSEcCtD
Ciclesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.00027	0.0101	CbGpPWpGaD
Ciclesonide—Hypertension—Gemcitabine—kidney cancer	0.00027	0.00117	CcSEcCtD
Ciclesonide—Infection—Vincristine—kidney cancer	0.000267	0.00116	CcSEcCtD
Ciclesonide—Conjunctivitis—Capecitabine—kidney cancer	0.000267	0.00116	CcSEcCtD
Ciclesonide—Urinary tract infection—Capecitabine—kidney cancer	0.000267	0.00116	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	0.000266	0.00997	CbGpPWpGaD
Ciclesonide—Arthralgia—Gemcitabine—kidney cancer	0.000266	0.00115	CcSEcCtD
Ciclesonide—Chest pain—Gemcitabine—kidney cancer	0.000266	0.00115	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—kidney cancer	0.000264	0.00114	CcSEcCtD
Ciclesonide—Asthenia—Erlotinib—kidney cancer	0.000263	0.00114	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SLC5A5—kidney cancer	0.000263	0.00986	CbGpPWpGaD
Ciclesonide—Urticaria—Sorafenib—kidney cancer	0.000262	0.00114	CcSEcCtD
Ciclesonide—Fatigue—Dactinomycin—kidney cancer	0.000259	0.00112	CcSEcCtD
Ciclesonide—Epistaxis—Capecitabine—kidney cancer	0.000259	0.00112	CcSEcCtD
Ciclesonide—Dysgeusia—Paclitaxel—kidney cancer	0.000256	0.00111	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SLC2A1—kidney cancer	0.000254	0.00952	CbGpPWpGaD
Ciclesonide—Infection—Gemcitabine—kidney cancer	0.000253	0.0011	CcSEcCtD
Ciclesonide—Back pain—Paclitaxel—kidney cancer	0.000253	0.00109	CcSEcCtD
Ciclesonide—Dizziness—Vinblastine—kidney cancer	0.000252	0.00109	CcSEcCtD
Ciclesonide—Dizziness—Everolimus—kidney cancer	0.000251	0.00109	CcSEcCtD
Ciclesonide—Haemoglobin—Capecitabine—kidney cancer	0.000248	0.00107	CcSEcCtD
Ciclesonide—Rhinitis—Capecitabine—kidney cancer	0.000247	0.00107	CcSEcCtD
Ciclesonide—Haemorrhage—Capecitabine—kidney cancer	0.000246	0.00107	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000245	0.00106	CcSEcCtD
Ciclesonide—Pharyngitis—Capecitabine—kidney cancer	0.000245	0.00106	CcSEcCtD
Ciclesonide—Dizziness—Erlotinib—kidney cancer	0.000243	0.00105	CcSEcCtD
Ciclesonide—Rash—Everolimus—kidney cancer	0.00024	0.00104	CcSEcCtD
Ciclesonide—Dermatitis—Everolimus—kidney cancer	0.000239	0.00104	CcSEcCtD
Ciclesonide—Headache—Vinblastine—kidney cancer	0.000239	0.00104	CcSEcCtD
Ciclesonide—Angioedema—Paclitaxel—kidney cancer	0.000239	0.00103	CcSEcCtD
Ciclesonide—Headache—Everolimus—kidney cancer	0.000238	0.00103	CcSEcCtD
Ciclesonide—Asthenia—Sorafenib—kidney cancer	0.000237	0.00103	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—EGR1—kidney cancer	0.000236	0.00884	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000232	0.00101	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000232	0.001	CcSEcCtD
Ciclesonide—Fatigue—Vincristine—kidney cancer	0.000232	0.001	CcSEcCtD
Ciclesonide—Rash—Erlotinib—kidney cancer	0.000231	0.001	CcSEcCtD
Ciclesonide—Dermatitis—Erlotinib—kidney cancer	0.000231	0.001	CcSEcCtD
Ciclesonide—Palpitations—Paclitaxel—kidney cancer	0.000231	0.001	CcSEcCtD
Ciclesonide—Headache—Erlotinib—kidney cancer	0.00023	0.000995	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—kidney cancer	0.00023	0.000994	CcSEcCtD
Ciclesonide—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000229	0.00859	CbGpPWpGaD
Ciclesonide—Cough—Paclitaxel—kidney cancer	0.000228	0.000988	CcSEcCtD
Ciclesonide—Asthenia—Sunitinib—kidney cancer	0.000228	0.000986	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—EPAS1—kidney cancer	0.000227	0.00853	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HNF1A—kidney cancer	0.000227	0.00853	CbGpPWpGaD
Ciclesonide—Dyspnoea—Gemcitabine—kidney cancer	0.000227	0.000984	CcSEcCtD
Ciclesonide—Nausea—Vinblastine—kidney cancer	0.000227	0.000981	CcSEcCtD
Ciclesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000226	0.00848	CbGpPWpGaD
Ciclesonide—Nausea—Everolimus—kidney cancer	0.000226	0.000978	CcSEcCtD
Ciclesonide—Hypertension—Paclitaxel—kidney cancer	0.000226	0.000977	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—ACHE—kidney cancer	0.000225	0.00843	CbGpPWpGaD
Ciclesonide—Immune system disorder—Capecitabine—kidney cancer	0.000223	0.000964	CcSEcCtD
Ciclesonide—Arthralgia—Paclitaxel—kidney cancer	0.000223	0.000963	CcSEcCtD
Ciclesonide—Chest pain—Paclitaxel—kidney cancer	0.000223	0.000963	CcSEcCtD
Ciclesonide—Mediastinal disorder—Capecitabine—kidney cancer	0.000222	0.000961	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—kidney cancer	0.000222	0.00096	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00022	0.000952	CcSEcCtD
Ciclesonide—Fatigue—Gemcitabine—kidney cancer	0.00022	0.000951	CcSEcCtD
Ciclesonide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000218	0.00819	CbGpPWpGaD
Ciclesonide—Dizziness—Sorafenib—kidney cancer	0.000218	0.000945	CcSEcCtD
Ciclesonide—Nausea—Erlotinib—kidney cancer	0.000218	0.000943	CcSEcCtD
Ciclesonide—Dry mouth—Paclitaxel—kidney cancer	0.000218	0.000942	CcSEcCtD
Ciclesonide—Asthenia—Dactinomycin—kidney cancer	0.000216	0.000934	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—kidney cancer	0.000215	0.00805	CbGpPWpGaD
Ciclesonide—Infection—Paclitaxel—kidney cancer	0.000212	0.000918	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTP1—kidney cancer	0.000212	0.00794	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000211	0.00793	CbGpPWpGaD
Ciclesonide—Methylprednisolone—ABCB1—kidney cancer	0.000211	0.0477	CrCbGaD
Ciclesonide—Dysgeusia—Capecitabine—kidney cancer	0.00021	0.000909	CcSEcCtD
Ciclesonide—Dizziness—Sunitinib—kidney cancer	0.00021	0.000909	CcSEcCtD
Ciclesonide—Rash—Sorafenib—kidney cancer	0.000208	0.000901	CcSEcCtD
Ciclesonide—Dermatitis—Sorafenib—kidney cancer	0.000208	0.0009	CcSEcCtD
Ciclesonide—Back pain—Capecitabine—kidney cancer	0.000207	0.000898	CcSEcCtD
Ciclesonide—Headache—Sorafenib—kidney cancer	0.000207	0.000895	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—kidney cancer	0.000205	0.000889	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN2A—kidney cancer	0.000204	0.00766	CbGpPWpGaD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000203	0.000877	CcSEcCtD
Ciclesonide—Rash—Sunitinib—kidney cancer	0.0002	0.000867	CcSEcCtD
Ciclesonide—Dermatitis—Sunitinib—kidney cancer	0.0002	0.000866	CcSEcCtD
Ciclesonide—Headache—Sunitinib—kidney cancer	0.000199	0.000861	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—kidney cancer	0.000198	0.000859	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	0.000197	0.00738	CbGpPWpGaD
Ciclesonide—Nausea—Sorafenib—kidney cancer	0.000196	0.000849	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTM1—kidney cancer	0.000195	0.0073	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000194	0.000841	CcSEcCtD
Ciclesonide—Asthenia—Vincristine—kidney cancer	0.000193	0.000834	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—kidney cancer	0.000191	0.000826	CcSEcCtD
Ciclesonide—Dyspnoea—Paclitaxel—kidney cancer	0.00019	0.000823	CcSEcCtD
Ciclesonide—Palpitations—Capecitabine—kidney cancer	0.00019	0.000821	CcSEcCtD
Ciclesonide—Rash—Dactinomycin—kidney cancer	0.00019	0.000821	CcSEcCtD
Ciclesonide—Nausea—Sunitinib—kidney cancer	0.000189	0.000817	CcSEcCtD
Ciclesonide—Dyspepsia—Paclitaxel—kidney cancer	0.000188	0.000813	CcSEcCtD
Ciclesonide—Cough—Capecitabine—kidney cancer	0.000187	0.00081	CcSEcCtD
Ciclesonide—Hypertension—Capecitabine—kidney cancer	0.000185	0.000802	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000184	0.000799	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000184	0.000797	CcSEcCtD
Ciclesonide—Fatigue—Paclitaxel—kidney cancer	0.000184	0.000796	CcSEcCtD
Ciclesonide—Asthenia—Gemcitabine—kidney cancer	0.000183	0.000791	CcSEcCtD
Ciclesonide—CYP2D6—Xenobiotics—CYP1A1—kidney cancer	0.000183	0.00685	CbGpPWpGaD
Ciclesonide—Chest pain—Capecitabine—kidney cancer	0.000183	0.000791	CcSEcCtD
Ciclesonide—Arthralgia—Capecitabine—kidney cancer	0.000183	0.000791	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN1B—kidney cancer	0.000181	0.00679	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	0.000181	0.00678	CbGpPWpGaD
Ciclesonide—Weight increased—Doxorubicin—kidney cancer	0.000181	0.000782	CcSEcCtD
Ciclesonide—Dry mouth—Capecitabine—kidney cancer	0.000179	0.000773	CcSEcCtD
Ciclesonide—Nausea—Dactinomycin—kidney cancer	0.000179	0.000773	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—kidney cancer	0.000178	0.000771	CcSEcCtD
Ciclesonide—Dizziness—Vincristine—kidney cancer	0.000178	0.000769	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—kidney cancer	0.000177	0.000766	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—kidney cancer	0.000177	0.000766	CcSEcCtD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000176	0.00659	CbGpPWpGaD
Ciclesonide—Infection—Capecitabine—kidney cancer	0.000174	0.000753	CcSEcCtD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000173	0.0065	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000173	0.00648	CbGpPWpGaD
Ciclesonide—Urinary tract infection—Doxorubicin—kidney cancer	0.000172	0.000745	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—kidney cancer	0.000172	0.000745	CcSEcCtD
Ciclesonide—Urticaria—Paclitaxel—kidney cancer	0.000169	0.000734	CcSEcCtD
Ciclesonide—Rash—Vincristine—kidney cancer	0.000169	0.000733	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	0.000169	0.00635	CbGpPWpGaD
Ciclesonide—Dermatitis—Vincristine—kidney cancer	0.000169	0.000733	CcSEcCtD
Ciclesonide—Headache—Vincristine—kidney cancer	0.000168	0.000728	CcSEcCtD
Ciclesonide—CYP2D6—Biological oxidations—ACY1—kidney cancer	0.000168	0.0063	CbGpPWpGaD
Ciclesonide—Epistaxis—Doxorubicin—kidney cancer	0.000167	0.000723	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	0.000167	0.00625	CbGpPWpGaD
Ciclesonide—Sinusitis—Doxorubicin—kidney cancer	0.000166	0.000719	CcSEcCtD
Ciclesonide—Prednisone—ABCB1—kidney cancer	0.000161	0.0365	CrCbGaD
Ciclesonide—Rash—Gemcitabine—kidney cancer	0.000161	0.000696	CcSEcCtD
Ciclesonide—Dermatitis—Gemcitabine—kidney cancer	0.000161	0.000695	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—kidney cancer	0.00016	0.000691	CcSEcCtD
Ciclesonide—Headache—Gemcitabine—kidney cancer	0.00016	0.000691	CcSEcCtD
Ciclesonide—Nausea—Vincristine—kidney cancer	0.00016	0.000691	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00016	0.000691	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—kidney cancer	0.000159	0.000689	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—kidney cancer	0.000159	0.000688	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	0.000159	0.00594	CbGpPWpGaD
Ciclesonide—Pharyngitis—Doxorubicin—kidney cancer	0.000158	0.000683	CcSEcCtD
Ciclesonide—Dyspnoea—Capecitabine—kidney cancer	0.000156	0.000676	CcSEcCtD
Ciclesonide—Dyspepsia—Capecitabine—kidney cancer	0.000154	0.000667	CcSEcCtD
Ciclesonide—Asthenia—Paclitaxel—kidney cancer	0.000153	0.000663	CcSEcCtD
Ciclesonide—Nausea—Gemcitabine—kidney cancer	0.000151	0.000655	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000151	0.000654	CcSEcCtD
Ciclesonide—Fatigue—Capecitabine—kidney cancer	0.000151	0.000653	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	0.000149	0.00559	CbGpPWpGaD
Ciclesonide—Prednisolone—ABCB1—kidney cancer	0.000149	0.0337	CrCbGaD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000148	0.00554	CbGpPWpGaD
Ciclesonide—Immune system disorder—Doxorubicin—kidney cancer	0.000143	0.000621	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—kidney cancer	0.000143	0.00062	CcSEcCtD
Ciclesonide—NR3C1—Circadian Clock—HIF1A—kidney cancer	0.000143	0.00535	CbGpPWpGaD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000143	0.00535	CbGpPWpGaD
Ciclesonide—Dizziness—Paclitaxel—kidney cancer	0.000141	0.000611	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.00014	0.00525	CbGpPWpGaD
Ciclesonide—Urticaria—Capecitabine—kidney cancer	0.000139	0.000602	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—MYC—kidney cancer	0.000139	0.00519	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000137	0.00514	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000136	0.00509	CbGpPWpGaD
Ciclesonide—Dysgeusia—Doxorubicin—kidney cancer	0.000135	0.000586	CcSEcCtD
Ciclesonide—Rash—Paclitaxel—kidney cancer	0.000135	0.000582	CcSEcCtD
Ciclesonide—Dermatitis—Paclitaxel—kidney cancer	0.000134	0.000582	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—kidney cancer	0.000134	0.000579	CcSEcCtD
Ciclesonide—Headache—Paclitaxel—kidney cancer	0.000134	0.000579	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000131	0.00491	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.00013	0.00487	CbGpPWpGaD
Ciclesonide—Nausea—Paclitaxel—kidney cancer	0.000127	0.000549	CcSEcCtD
Ciclesonide—Asthenia—Capecitabine—kidney cancer	0.000126	0.000544	CcSEcCtD
Ciclesonide—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000124	0.00467	CbGpPWpGaD
Ciclesonide—Palpitations—Doxorubicin—kidney cancer	0.000122	0.000529	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—kidney cancer	0.000121	0.000522	CcSEcCtD
Ciclesonide—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000119	0.00448	CbGpPWpGaD
Ciclesonide—Hypertension—Doxorubicin—kidney cancer	0.000119	0.000517	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	0.000118	0.00442	CbGpPWpGaD
Ciclesonide—Chest pain—Doxorubicin—kidney cancer	0.000118	0.00051	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—kidney cancer	0.000118	0.00051	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000118	0.00441	CbGpPWpGaD
Ciclesonide—Dizziness—Capecitabine—kidney cancer	0.000116	0.000501	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—kidney cancer	0.000115	0.000498	CcSEcCtD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000115	0.00431	CbGpPWpGaD
Ciclesonide—Hydrocortisone—ABCB1—kidney cancer	0.000114	0.0257	CrCbGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000113	0.00425	CbGpPWpGaD
Ciclesonide—Infection—Doxorubicin—kidney cancer	0.000112	0.000485	CcSEcCtD
Ciclesonide—Rash—Capecitabine—kidney cancer	0.00011	0.000478	CcSEcCtD
Ciclesonide—Dermatitis—Capecitabine—kidney cancer	0.00011	0.000477	CcSEcCtD
Ciclesonide—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.00011	0.00412	CbGpPWpGaD
Ciclesonide—Headache—Capecitabine—kidney cancer	0.00011	0.000475	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—APC—kidney cancer	0.000106	0.00398	CbGpPWpGaD
Ciclesonide—Nausea—Capecitabine—kidney cancer	0.000104	0.00045	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000103	0.000445	CcSEcCtD
Ciclesonide—Dyspnoea—Doxorubicin—kidney cancer	0.000101	0.000436	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—kidney cancer	9.93e-05	0.00043	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.74e-05	0.000422	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—kidney cancer	9.73e-05	0.000421	CcSEcCtD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	9.54e-05	0.00358	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	9.2e-05	0.00345	CbGpPWpGaD
Ciclesonide—Urticaria—Doxorubicin—kidney cancer	8.96e-05	0.000388	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	8.91e-05	0.00334	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	8.91e-05	0.00334	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	8.87e-05	0.00333	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	8.7e-05	0.00326	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	8.49e-05	0.00318	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	8.42e-05	0.00316	CbGpPWpGaD
Ciclesonide—Asthenia—Doxorubicin—kidney cancer	8.1e-05	0.000351	CcSEcCtD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.58e-05	0.00284	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.49e-05	0.00281	CbGpPWpGaD
Ciclesonide—Dizziness—Doxorubicin—kidney cancer	7.46e-05	0.000323	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	7.46e-05	0.0028	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	7.3e-05	0.00274	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HARS—kidney cancer	7.3e-05	0.00274	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	7.21e-05	0.0027	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HIF1A—kidney cancer	7.18e-05	0.00269	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	7.14e-05	0.00268	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	7.12e-05	0.00267	CbGpPWpGaD
Ciclesonide—Rash—Doxorubicin—kidney cancer	7.12e-05	0.000308	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—kidney cancer	7.11e-05	0.000308	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	7.1e-05	0.00266	CbGpPWpGaD
Ciclesonide—Headache—Doxorubicin—kidney cancer	7.07e-05	0.000306	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	7.05e-05	0.00264	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	6.87e-05	0.00258	CbGpPWpGaD
Ciclesonide—Nausea—Doxorubicin—kidney cancer	6.7e-05	0.00029	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	6.43e-05	0.00241	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	6.32e-05	0.00237	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	6.26e-05	0.00235	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	6.24e-05	0.00234	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF5B—kidney cancer	6.21e-05	0.00233	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	6.2e-05	0.00233	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.15e-05	0.00231	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	6.13e-05	0.0023	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	6.02e-05	0.00226	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	5.71e-05	0.00214	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.66e-05	0.00212	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTT1—kidney cancer	5.41e-05	0.00203	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	5.17e-05	0.00194	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	5.08e-05	0.0019	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—PTGS1—kidney cancer	5.07e-05	0.0019	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.96e-05	0.00186	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	4.92e-05	0.00184	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.89e-05	0.00183	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	4.69e-05	0.00176	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.58e-05	0.00172	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CTNNB1—kidney cancer	4.29e-05	0.00161	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	4.13e-05	0.00155	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	4.03e-05	0.00151	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.02e-05	0.00151	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EEF2—kidney cancer	4e-05	0.0015	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TET2—kidney cancer	3.83e-05	0.00144	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—kidney cancer	3.75e-05	0.00141	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	3.74e-05	0.0014	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.71e-05	0.00139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	3.7e-05	0.00139	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.7e-05	0.00139	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.54e-05	0.00133	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TCEB2—kidney cancer	3.51e-05	0.00131	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TCEB1—kidney cancer	3.51e-05	0.00131	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—kidney cancer	3.45e-05	0.00129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	3.4e-05	0.00127	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.31e-05	0.00124	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	3.28e-05	0.00123	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.27e-05	0.00123	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	3.27e-05	0.00122	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3.22e-05	0.00121	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3e-05	0.00112	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACY1—kidney cancer	2.87e-05	0.00108	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL14—kidney cancer	2.85e-05	0.00107	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.45e-05	0.000919	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PDHB—kidney cancer	2.44e-05	0.000916	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—POMC—kidney cancer	2.44e-05	0.000913	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.42e-05	0.000906	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.32e-05	0.000871	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPB1—kidney cancer	2.32e-05	0.000871	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CCBL1—kidney cancer	2.3e-05	0.000861	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.25e-05	0.000845	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.22e-05	0.000833	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PSMD7—kidney cancer	2.16e-05	0.00081	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.14e-05	0.000801	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.11e-05	0.00079	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.99e-05	0.000747	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPAT—kidney cancer	1.99e-05	0.000747	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—JUNB—kidney cancer	1.94e-05	0.000727	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACY1—kidney cancer	1.88e-05	0.000704	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APRT—kidney cancer	1.85e-05	0.000694	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FH—kidney cancer	1.85e-05	0.000694	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPC3—kidney cancer	1.74e-05	0.000653	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA2—kidney cancer	1.69e-05	0.000635	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALAD—kidney cancer	1.65e-05	0.000619	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.61e-05	0.000604	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PDHB—kidney cancer	1.6e-05	0.000599	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.59e-05	0.000597	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.58e-05	0.000592	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.57e-05	0.00059	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PGK1—kidney cancer	1.51e-05	0.000566	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.51e-05	0.000566	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.5e-05	0.000563	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LDHB—kidney cancer	1.48e-05	0.000555	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPAT—kidney cancer	1.3e-05	0.000488	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.3e-05	0.000488	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA9—kidney cancer	1.28e-05	0.000481	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.27e-05	0.000476	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FH—kidney cancer	1.21e-05	0.000454	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APRT—kidney cancer	1.21e-05	0.000454	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPC3—kidney cancer	1.14e-05	0.000427	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA2—kidney cancer	1.11e-05	0.000415	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CRABP1—kidney cancer	1.09e-05	0.000409	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALAD—kidney cancer	1.08e-05	0.000405	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.05e-05	0.000395	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.03e-05	0.000386	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ITPR2—kidney cancer	1.01e-05	0.00038	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.87e-06	0.00037	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PGK1—kidney cancer	9.87e-06	0.00037	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LDHB—kidney cancer	9.68e-06	0.000363	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACHE—kidney cancer	9.25e-06	0.000347	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—kidney cancer	9.25e-06	0.000347	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SCARB1—kidney cancer	8.76e-06	0.000328	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS1—kidney cancer	8.67e-06	0.000325	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PSMD7—kidney cancer	8.5e-06	0.000319	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA9—kidney cancer	8.39e-06	0.000315	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCHE—kidney cancer	8.06e-06	0.000302	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A5—kidney cancer	7.96e-06	0.000298	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A1—kidney cancer	7.69e-06	0.000288	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CRABP1—kidney cancer	7.13e-06	0.000267	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ITPR2—kidney cancer	6.63e-06	0.000249	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—kidney cancer	6.41e-06	0.00024	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—kidney cancer	6.29e-06	0.000236	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—kidney cancer	6.12e-06	0.000229	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—kidney cancer	6.07e-06	0.000228	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACHE—kidney cancer	6.05e-06	0.000227	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—kidney cancer	6.05e-06	0.000227	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—kidney cancer	5.89e-06	0.000221	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SCARB1—kidney cancer	5.72e-06	0.000215	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS1—kidney cancer	5.67e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.59e-06	0.000209	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PSMD7—kidney cancer	5.56e-06	0.000208	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCHE—kidney cancer	5.27e-06	0.000198	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.2e-06	0.000195	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.03e-06	0.000188	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—kidney cancer	4.19e-06	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—POMC—kidney cancer	4.16e-06	0.000156	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—kidney cancer	3.97e-06	0.000149	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—kidney cancer	3.85e-06	0.000144	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.65e-06	0.000137	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—kidney cancer	3.32e-06	0.000125	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—kidney cancer	2.9e-06	0.000109	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—POMC—kidney cancer	2.72e-06	0.000102	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—kidney cancer	2.17e-06	8.14e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.04e-06	7.66e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—kidney cancer	1.89e-06	7.1e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.34e-06	5.01e-05	CbGpPWpGaD
